YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

20th-Oct-2020 10:02Source: BSE

Cadila Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets

Sections